CalciMedica is trading 5.53% up in after-hours trading at $0.62 after closing at $0.59 on August 26, 2026, with no verified new company-specific catalyst.
- No verified August 26 company announcement appears on CalciMedica’s investor-relations release page; its latest listed release is dated August 11.
- Recent Guggenheim coverage initiated a buy rating, but the August 20 catalyst is not new.
- Broader markets were modestly firmer, offering limited context; the precise after-hours driver remains unclear.